Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain reduction over the first Phase 3 trial despite not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback